Stock Earnings

Question 1

What are TherapeuticsMD Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), TherapeuticsMD Inc has a total asset of $38, Net loss of $-2

Question 2

What are the key financial ratios for TXMD?

Accepted Answer

TherapeuticsMD Inc's Current ratio is 3.45, has a Net margin is -200, sales per share of $0.08.

Question 3

How is TherapeuticsMD Inc's revenue broken down by segment or geography?

Accepted Answer

TherapeuticsMD Inc largest revenue segment is License, at a revenue of 1,302,000 in the most earnings release.For geography, United States is the primary market for TherapeuticsMD Inc, at a revenue of 1,302,000.

Question 4

Is TherapeuticsMD Inc profitable?

Accepted Answer

no, according to the latest financial statements, TherapeuticsMD Inc has a net loss of $-2

Question 5

Does TherapeuticsMD Inc have any liabilities?

Accepted Answer

yes, TherapeuticsMD Inc has liability of 11

Question 6

How many outstanding shares for TherapeuticsMD Inc?

Accepted Answer

TherapeuticsMD Inc has a total outstanding shares of 11.53

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2	1	1	69	2	64
Revenue Growth (YoY)	100%	0%	-99%	3,350%	-97%	31%
Cost of Revenue	--	--	0	1	1	15
Gross Profit	--	--	1	68	1	48
Selling, General & Admin	5	4	8	57	80	192
Research & Development	--	--	--	0	0	10
Operating Expenses	5	5	9	57	80	204
Other Non Operating Income (Expenses)	2	2	0	0	0	0
Pretax Income	0	-2	-7	1	-79	-183
Income Tax Expense	0	0	0	0	0	0
Net Income	0	-2	-10	112	-172	-183
Net Income Growth	-100%	-80%	-109%	-165%	-6%	4%
Shares Outstanding (Diluted)	11.57	11.53	10.44	9.37	7.96	5.51
Shares Change (YoY)	0%	10%	11%	18%	44%	12%
EPS (Diluted)	0	-0.2	-0.98	11.95	-21.66	-33.29
EPS Growth	-102%	-80%	-108%	-155%	-35%	-7%
Free Cash Flow	2	0	-48	-4	-144	-161
Free Cash Flow Per Share	0.17	0	-4.59	-0.42	-18.09	-29.21
Gross Margin	--	--	100%	98.55%	50%	75%
Operating Margin	-100%	-300%	-800%	14.49%	-3,950%	-242.18%
Profit Margin	0%	-200%	-1,000%	162.31%	-8,600%	-285.93%
Free Cash Flow Margin	100%	0%	-4,800%	-5.79%	-7,200%	-251.56%
EBITDA	-2	-3	-8	11	-79	-154
EBITDA Margin	-100%	-300%	-800%	15.94%	-3,950%	-240.62%
D&A For EBITDA	0	0	0	1	0	1
EBIT	-2	-3	-8	10	-79	-155
EBIT Margin	-100%	-300%	-800%	14.49%	-3,950%	-242.18%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

TherapeuticsMD Inc (TXMD) Price

TXMD Stock Price Chart

TXMD Income

Follow-Up Questions